IF a five-modality Integrated GlycoSENS Biomarker Panel (iGBP)—comprising (i) non-invasive tail-skin autofluorescence (SAF) sampled at baseline, 6-week, and 12-week intervals; (ii) spot-urine isotope-dilution LC-MS/MS for free pentosidine (longitudinal liberation proxy); (iii) serial tail-tendon micro-biopsy LC-MS/MS for tissue-bound glucosepane and pentosidine per hydroxyproline; (iv) terminal aortic and renal cortex LC-MS/MS for CML, CEL, MOLD, and GOLD; and (v) pulsed-SILAC collagen turnover labelling at study endpoint—is applied to aged (22-month-old) male and female C57BL/6J mice receiving the full RMR2 multi-intervention stack (rapamycin + senolytic + partial reprogramming + anti-IL-11 + MSC infusion ± oxytocin),

THEN the iGBP will: (a) reveal that currently used RMR2 interventions produce a measurable, intervention-specific reduction in tissue-bound tail-tendon glucosepane burden (≥15–25% vs. aged vehicle controls at 12 weeks) that is invisible to all standard aging assays; (b) demonstrate that urine free-pentosidine rises transiently (weeks 2–4) before tail-tendon bound-pentosidine falls, providing a pharmacodynamic release signature; and (c) identify anti-IL-11 as the single RMR2 component most responsible for ECM crosslink turnover, via its disproportionate contribution to pulsed-SILAC collagen fractional synthesis rate,

BECAUSE the following causal chain is supported by the evidence:

1. Glucosepane accumulates linearly with murine chronological age in tail-tendon type I collagen and is the dominant inter-molecular crosslink quantifiable by isotope-dilution LC-MS/MS, yet is completely undetectable by fluorescence-based or immunological assays, meaning it is a dark endpoint in every existing rodent aging panel (Glucosepane and pentosidine increase with age in mouse tail tendon; glucosepane rises approximately linearly while absolute pentosidine remains far lower, as shown by collagen biochemistry)[https://doi.org/10.1074/jbc.ra119.011031]

2. Pentosidine and other fluorescent AGEs in blood and urine can serve as indirect, accessible surrogates for tissue crosslink burden; serum pentosidine shows consistent positive correlation with age (r = 0.359) and crucially with tissue pentosidine, establishing the biofluid-to-tissue proxy principle necessary for longitudinal tracking without terminal sacrifice at every time point (Non-invasive skin autofluorescence, serum, and urine pentosidine as indirect indicators of tissue AGE content)[https://doi.org/10.1186/s12891-019-3011-4]

3. Skin autofluorescence independently predicts chronic kidney disease progression in pre-dialysis patients, demonstrating that a non-invasive, repeatable optical endpoint captures biologically meaningful AGE burden at systemic scale and can serve as a weekly or monthly readout in longitudinal mouse cohorts without any sampling bias from biopsy (Skin autofluorescence predicts CKD progression)[https://doi.org/10.1371/journal.pone.0083799]

4. Pulsed-SILAC in mice dir...

SENS category: GlycoSENS

Key references: • doi.org/10.1074/jbc.ra119.011031] • doi.org/10.1186/s12891-019-3011-4] • doi.org/10.1371/journal.pone.0083799] • doi.org/10.7554/eLife.666351of20] • doi.org/10.1016/j.bone.2018.01.028]